Ligand Pharmaceuticals Inc (LGND) — SEC Filings
Ligand Pharmaceuticals Inc (LGND) — 2 SEC filings. Latest: 10-Q (May 8, 2026). Includes 1 10-Q, 1 8-K.
View Ligand Pharmaceuticals Inc on SEC EDGAR
Overview
Ligand Pharmaceuticals Inc (LGND) is a publicly traded company with 2 SEC filings tracked on ReadTheFiling.
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant filing sentiment for Ligand Pharmaceuticals Inc is neutral.
Filing Type Overview
Ligand Pharmaceuticals Inc (LGND) has filed 1 10-Q, 1 8-K with the SEC between May 2026.
Recent SEC Filings (2)
| Date | Form | Description | Risk |
|---|---|---|---|
| May 8, 2026 | 10-Q | 10-Q Filing | |
| May 7, 2026 | 8-K | 8-K Filing |
Frequently Asked Questions
What are the latest SEC filings for Ligand Pharmaceuticals Inc (LGND)?
Ligand Pharmaceuticals Inc has 2 recent SEC filings from May 2026, including 1 10-Q, 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of LGND filings?
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant sentiment is neutral.
Where can I find Ligand Pharmaceuticals Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ligand Pharmaceuticals Inc (LGND) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ligand Pharmaceuticals Inc?
Financial highlights for Ligand Pharmaceuticals Inc are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for LGND?
Investment thesis data for LGND will be available once enriched filings are processed.
Who are the key executives at Ligand Pharmaceuticals Inc?
Executive information for Ligand Pharmaceuticals Inc is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Ligand Pharmaceuticals Inc stock?
Risk factor analysis for Ligand Pharmaceuticals Inc is available when filings are enriched with AI risk assessment.
What are recent predictions and forward guidance from Ligand Pharmaceuticals Inc?
Forward guidance and predictions for Ligand Pharmaceuticals Inc are extracted from SEC filings as they are enriched.